Contact No: +91-8826373757 | +91-8826859373 | 011-25052216
Email: rakesh.its@gmail.com | editor@innovativepublication.com

COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Covid-19 Special Issue


About Journal

Covid-19 Special Issue started as taking care of Coronavirus Pandemic (COVID-19) as an open access, double-blind peer-review journal  under "IP Indian Journal of Immunology and Respiratory Medicine" our on publishing monthly since 2020. The full text of the journal is available online at https://www.innovativepublication.com/journals/COVID/archive. Covid Special Issue  comes under IP Indian Journal of Immunology and Respiratory Medicine, Print ISSN 2881-4214,e-ISSN: 25814222  proclaimed by Khyati Education and Research Foundation, Online published by Innovative Publication. Journal permits authors to self-archive final approval of the articles on any OAI-compliant institutional/subject-based repository.

Aim and Scope

SARS-CoV-2, is a positive-strand RNA virus belonging to the family of single-stranded RNA viruses known as coronaviridae, Nidovirales order and thus was belived to be a common type of virus which usually affects mammals, birds and reptiles, but no previous reportes of infection in humans. Covid-19 Special Issue devoted to publish the detailed information about novel corona virus which can help us to cure this pandemic. We started this journal for helping our society. The scope is therefore huge covering almost all streams related with covid-19 starting from original research articles, review articles, short communications, and clinical cases as well as studies covering clinical, experimental and applied topics on Covid-19. The scope of the journal isn't restricted however it's the broader coverage of all the newest updates and specialties.